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Abstract Recent evidence suggests tha  a number of non-phagocytic cell types may contain a superoxide generating NADPH oxidase. Studies to 
date on cultured human fibroblasts have primarily concerned the identification of cytochrome b558, whilst expression f other NADPH oxidase 
components have notbeen addressed. In this study we have investigated the expression of NADPH oxidase with particular reference to the cytosolic 
factors p47-phox and p67-phox. Reverse transcriptase-polymerase ch in reaction (RT-PCR) showed that human fibroblasts express mRNA for 
p47-phox, p67-phox and p22-phox. Expression of the gp91-phox transcript was not detected, indicating that human fibroblasts may possess an 
NADPH oxidase isoenzyme. Western blot analysis of human fibroblast cytosol, using an anti-p47-phox antibody (JW-1), identified a 47kDa protein. 
Cell-free reconstitution assays showed that fibroblast cytosol could initiate superoxide generation when mixed with either uman fibroblast 
membranes (0.16 nmol superoxide/min//tg membrane protein), or r sting human neutrophil membranes (0.20 nmol superoxide/min//zg membrane 
protein). These data indicate that he expression of p47-phox and p67-phox by human fibroblasts may contribute to thecells' generation f superoxide. 
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1. Introduction 
The generation of superoxide isprimarily associated with the 
microbicidal ctivity of phagocytic leukocytes, uch as neutro- 
phils and macrophages. In these cells, superoxide is produced 
by a multi-component enzyme system, which facilitates the 
reduction of oxygen to superoxide through the oxidation of 
cytosolic NADPH. This enzyme, known as the NADPH oxi- 
dase (see [1,2] for reviews), consists of a membrane-bound fla- 
vocytochrome b (cytochrome b558), consisting of a small 22 kDa 
subunit (p22-phox) and a larger 90-110 kDa glycoprotein sub- 
unit (gp91-phox)[3]. The redox mid-point potential of cyto- 
chrome b558 (Era.7 -- -245 mV [4]) is sufficiently low to facilitate 
the single electron reduction of oxygen to superoxide 
(Era.7 = -160 mV [5]). Sequence comparisons with known pyri- 
dine nucleotide binding proteins have suggested that gp91-phox 
may contain NADPH and FAD binding sites [6-8]. In addition 
to these membrane-bound components, a number of cytosolic 
factors (p47-phox, p67-phox and p21rac) are required for en- 
zyme activity [9-11]. These components translocate to the 
membrane on activation where they initiate superoxide produc- 
tion [12]. Although precise functions for p47-phox and p67- 
phox have not yet been elucidated, their importance in the 
NADPH oxidase is clearly demonstrated by their absence in 
autosomal forms of the genetic disorder chronic granuloma- 
tous disease (CGD) (see [13] for review). 
Recent studies have demonstrated that a number of non- 
phagocytic ell types, including fibroblasts [14], generate low 
levels of superoxide, often in response to specific stimuli (see 
[15] for review). Although numerous roles have been suggested 
for this production, both the source and function of non- 
phagocyte-derived superoxide remains unknown (see [16] for 
review). One possible source for the production of superoxide 
is an NADPH oxidase-like system. In particular, human fibro- 
blasts [17] and human glomerular mesangial cells [18] have been 
shown to contain a membrane-bound b-type cytochrome with 
spectroscopic characteristics of cytochrome b558. Furthermore, 
human glomerular mesangial cells express mRNA for p47-phox 
[19]. Additional work by Meier et al. [20] suggested that the 
cytochrome b558 of human fibroblasts was structurally and ge- 
netically distinct from the b-type cytochrome of the neutrophil 
NADPH oxidase. However, to date, no study has examined the 
expression of the cytosolic factors in human fibroblasts. 
In this present communication we provide evidence which 
supports the presence of an NADPH oxidase-like system in 
human fibroblasts and demonstrate that these cells express 
mRNA for p22-phox, p47-phox and p67-phox. We also show 
the expression of p47-phox at the protein level in fibroblast 
cytosol and demonstrate that fibroblast cytosol can initiate 
superoxide generation in a heterologous cell-free reconstitution 
system. The functional expression of these components may 
contribute to the generation of superoxide by human fibro- 
blasts. 
2. Materials and methods 
2.1. Culture of human fibroblasts 
Human fibroblast cultures (kindly provided by Dr. V.B. O'Donnell, 
Rowett Research Institute, Aberdeen, Scotland) were obtained from 
individuals with Dupuytren's contracture. Cells were propagated in 
RPMI 1640 (Gibco-BRL) containing 10% (v/v) foetal calf serum (FCS) 
(Northumbria Biologicals Ltd.), 2 mM L-glutamine, 100/~g/ml strepto- 
mycin and 100 U/ml penicillin (all supplied by Gibco-BRL). Fibroblast 
cultures were incubated at 37°C with a 5% CO2 atmosphere and grew 
as a distinct adherent monolayer. Cells were passaged using trypsin/ 
EDTA/glucose (0.125% w/v: 0.01% w/v: 0.1% w/v). All experiments 
were performed on cultured cells between the 6th and 10th passage. 
*Corresponding author. 
Abbreviations: RT-PCR, reverse transcriptase-polymerase chain reac- 
tion; phox, phagocytic oxidase (components of NADPH oxidase). 
2.2. Isolation oftotal RNA 
Fibroblast cultures were washed in phosphate buffered saline (pH 
7.4) and lysed by the addition of RNAzol B (Biogenesis Ltd.). Total 
RNA was subsequently isolated using the protocol outlined by the 
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manufacturer of RNAzol B. RNA concentrations were determined 
spectroscopically b measuring the absorbance at 260 nm. The intre- 
grity of the sample was assessed by measuring the 260 nm: 280 nm ratio 
and by ethidium bromide staining of the RNA in a 2% (w/v) agarose 
gel (Ultrapure, BRL). Aliquots of total RNA extracts were stored at 
-70°C as precipitates in 50% ethanol containing 1.6 M ammonium 
acetate. 
2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
Total cellular RNA was reverse transcribed into eDNA, using the 
random hexanucleotide primer method previously described by 
O'Bryan et al. [21]. 
PCR amplification was performed in a Perkin Elmer thermocycler 
(Perkin Elmer-Cetus) using the method outlined by Topley et al. [22]. 
Differential PCR [23] was carded out with ~t-actin as a reference gene. 
Products of PCR amplification were separated on a 2% (w/v) NuSieve 
(Flowgen Ltd.), 1% (w/v) agarose gel containing ethidium bromide and 
visualised by UV transillumination. 
Information regarding all the oligonucleotide primers used in this 
study is shown in Table 1. These oligonueleotide primers have previ- 
ously been shown to generate correctly sized products in human mon- 
ocytes, EBV-transformed B-lymphocytes and human glomerular 
mesangial cells (Jones et al., in press; Wood et al., submitted for publi- 
cation). Sequencing of these DNA products howed that they share 
greater than 98% homology with their neutrophil counterparts. 
2.4. Isolation of membranes and cytosol 
Membranes and cytosol were isolated from sub-confluent human 
fibroblasts by differential centrifugation fcell lysates. Briefly, cultured 
fibroblasts were washed three times in 50 mM Tris, 1 mM EDTA (pH 
7.5) containing 1 mM PMSF and 1 mM benzamidine (extraction 
buffer). Flasks were broken open and the adherent cells scraped into 
one corner with 300/al of extraction buffer. Cell lysates were pooled 
from 15-20 T75 tissue culture flasks and sonicated on ice, with three 
15-20 s 50W bursts. The sonicate was centrifuged (9,000 x g for 10 min 
at 40C) to remove mitochondria, sub-cellular organelles and nuclei. The 
resultant supernatant was centrifuged at 100,000 x g for 45 min at 4 ° C. 
The supernatant containing the cytosolic proteins was collected and the 
plasma membrane pellet resuspended in 50/al extraction buffer. Protein 
concentrations were determined by the method of Bradford [24]. 
To concentrate the fibroblast cytosol for Western blot analysis, pro- 
teins were precipitated on ice with 10% trichloroacetic a id (TCA). The 
protein precipitate was pelletted in a microfuge, washed twice in ace- 
tone and air dried. Proteins were resuspended in SDS-PAGE sample 
buffer and boiled for 2-3 min prior to electrophoresis. 
Human neutrophils were isolated from buffy coats (supplied by the 
South West Regional Transfusion Service, Southmead Hospital, Bris- 
tol) as previously described by Segal and Jones [25]. Membrane and 
cytosol fractions were prepared from resting neutrophils by differential 
centrifugation fdisrupted cells as described for fibroblasts. The super- 
natant, containing the cytosolic proteins, and the membrane pellet were 
suspended at approximately 4 mg/ml in PBS and stored at -80°C. 
2.5. Western blot analysis 
Cytosolic proteins derived from both resting neutrophils and fibro- 
blasts were separated by SDS-PAGE in a 10% separating gel. Proteins 
were transferred to a nitrocellulose membrane by electroblotting at 100 
V for 60 min on ice and probed with a polyclonal antibody (JW-1) 
raised against a C-terminal peptide of p47-phox (residues 367-390: 
PRPSADLILNRCSESTKRKLASAC). Western blots were performed 
using Enhanced Chemiluminescence (Amersham), as previously de- 
scribed by Gorlach et al. [26]. 
2.6. Cell-free r constitution assay 
Superoxide generation was assessed in a cell-free reconstitution sys- 
tem using the method of Bromberg and Pick [27]. Briefly, combinations 
of membrane (5/ag) and cytosol (100/ag) in PBS (pH 7.4), derived from 
either fibroblasts or resting neutrophils, were incubated for 5 rain at 
room temperature in the presence of 15/aM GTPy-S and 40/aM sodium 
arachidonate (both supplied by Sigma). This mixture was added to 
cytoehrome c (type IV, Sigma) and the assay performed in a total 
volume of 1 ml. The final concentration f cytochrome c was 100/aM. 
NADPH (100/aM) was then added and the production of superoxide 
measured at 22°C using the superoxide dismutase (SOD)-inhibitable 
reduction of cytochrome c as previously described [28]. 
3. Results 
3.1. mRNA expression of  NADPH oxidase components by 
human fibroblasts 
We have examined the mRNA expression of gp91-phox, p22- 
phox, p47-phox and p67-phox by cultured human fibroblasts 
using specific oligonucleotide primers (Table 1), designed from 
the known neutrophil eDNA sequences. 
Total RNA was isolated from sub-confluent human fibro- 
blasts, which had been cultured in 10% FCS. This RNA was 
reverse transcribed into eDNA and used as a template for 
RT-PCR. Amplification of  this cDNA showed that fibroblasts 
express mRNA for p47-phox, p67-phox and p22-phox, at least 
within the designated primer regions (Fig. 1). The data obtained 
from RT-PCR suggested that the relative abundance of the 
p22-phox transcript was greater than that of p47-phox and 
p67-phox. 
Oligonucleotide primers were designed corresponding to 
both the 5' (gp915-phox: site of amplification 25-408 base pairs) 
Table 1 
Sequence information regarding the oligonucleotide primers used in this study 
Gene Primer sequence (5'-3') Product 
Forward GGAGCAATGATCTTGATCTT (20mer) 
actin*' Reverse TCCTGAGGTACGGGTCCTTCC (21mer) 204bp 
Forward GTTTGTGTGCCTGCTGGAGT (20mer) 
p22-phox Reverse TGGGCGGCTGCTTGATGGT (19mer) 316 bp 
Forward TGGGCTGTGAATGAGGGGCT (20mer) 
gp9]5-phox Reverse TGACTCGGGCATTCACACAC (20mer) 383 bp 
Forward GCTGTTCAATGCTTGTGGCT (20mer) 
gp913-phox Reverse TCTCCTCATCATGGTGCACA (20mer) 403 bp 
Forward ACCCAGCCAGCACTATGTGT (20mer) 
p47-phox Reverse AGTAGCCTGTGACGTCGTCT (20mer) 767 bp 
Forward CGA~AACCAGCTGATAGA (20mer) 
p67-phox Reverse CAT~AACACTGAGCTTCA (20mer) 746 bp 
*1. Oligonucleotide primer sequences obtained from O'Bryan et al. (1991). 
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and 3' (gp913-phox: site of amplification 1107-1510 base pairs) 
ends of the gp91-phox encoding transcript (Table 1). The results 
obtained using the gp913-phox pair of oligonucleotide primers 
are shown in Fig. 1. The RT-PCR specific amplification of 
~t-actin (204 base pairs) was used as an internal standard. No 
expression of gp91-phox transcript could be detected in human 
fibroblasts (Fig. 1) using either set of primers even after 
gp91-phox p47-phox 
M 1 2 3 1 2 3 
p47-phox (767 bp) > 
gp91-phox (403 bp) > 
actin (204 bp) > 
p67-phox p22-phox 
M 1 2 3 1 2 3 
p67-phox (746 bp) • 
p22-phox (316 bp) > 
Fig. 1. RT-PCR amplification of NADPH oxidase components from 
human fibroblast cDNA. Total cellular RNA was isolated from human 
fibroblasts. 1 pg of total RNA was reverse transcribed into cDNA and 
used as a template in RT-PCR. Specific oligonucleotide primers were 
used to generate PCR products for p22-phox (25 cycles), gp91phox 
(gp913phox, 35 cycles), p47-phox (35 cycles) and p67-phox (38 cycles). 
A portion of gp91phox PCR amplification products was mixed with a 
portion from a 25 cycle ct-actin (204 base pairs) amplification and 
separated on a 2% (w/v) NuSeive (Flowgen), 1% (w/v) agarose gel 
containing ethidium bromide. The separated products were visualised 
under UV illumination and sized using 123 base pair markers (Gibco- 
BRL) as molecular weight standards (M). Lane 1, human fibroblast 
cDNA; lane 2, reverse transcriptase-negative control reaction; lane 3, 
PCR-negative control reaction, gp913-phox, primer pairs located at the 
3' end of the gp91-phox transcript ( arget site, 1107-1510 base pairs). 
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Fig. 2. Western blot analysis of human fibroblast cytosol u ing an 
anti-p47-phox antibody. Cytosolic proteins were isolated from human 
fibroblasts and concentrated byTCA-precipitation. The proteins were 
separated by SDS-PAGE on a 10% polyacrylamide g l and Western 
blotted. The proteins were probed with a polyclonal anti p47-phox 
antibody raised in rabbits against a C-terminal peptide (amino acid 
residues 367-390). Lane 1 represents 10 #g of PMA-activated neutro- 
phil membranes, lane 2 represents 50 #g of human fibroblast cytosol. 
40 amplification cycles (data not shown), indicating either a 
variation within, or absence of, this protein component. 
3.2. Protein expression of p47-phox 
To substantiate he expression of p47-phox by human fibro- 
blasts, Western blot analysis was performed on fibroblast cy- 
tosolic proteins which had been concentrated by TCA-precipi- 
tation. This cytosolic fraction was probed with a polyclonal 
anti-p47-phox antibody (JW-1), which was raised against a C- 
terminal peptide of p47-phox. Immunodetection analysis 
showed the presence of a 47 kDa band in neutrophil cytosol, 
the electrophoretic mobility of which corresponds to a protein 
identified in human fibroblast cytosol (Fig. 2). 
3.3. Cell-free reconstitution 
To establish whether human fibroblast cytosol could main- 
tain a SOD-inhibitable production of superoxide, a cell-free 
reconstitution assay was employed. Membrane and cytosol 
fractions obtained from fibroblasts and resting neutrophils 
were recombined (see Table 2) in the presence of GTP~,-S and 
sodium arachidonate. Superoxide generation was initiated by 
the addition of NADPH. 
Table 2 shows that superoxide generation by either neutro- 
phil of fibroblast membranes could be initiated by fibroblast 
cytosol. As in whole cells [14], rates of superoxide production 
in the fibroblast reconstitution system were low, approximately 
1% of that of the neutrophil control. 
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4. Discussion 
Meier et al. [17] previously reported the identification of a 
low potential cytochrome b (Em,7 = -243 mV) in the plasma 
membrane of human fibroblasts. This b-type cytochrome had 
spectroscopic characteristics similar to those of cytochrome 
bsss- Therefore a system analogous to the NADPH oxidase of 
phagocytic leukocytes may be a candidate for the production 
of fibroblast-derived superoxide. 
The data presented in this manuscript demonstrates that 
human fibroblasts express mRNA for p22-phox, p47-phox and 
p67-phox. The relative abundance of the p47-phox and p67- 
phox transcripts were found to be lower than the expression of 
p22-phox. In addition a notable absence of detectable gp91- 
phox transcript was observed. A recent study by Meier et al. 
[20] showed that antibodies raised against he subunits of cyto- 
chrome b55s (gp91-phox and p22-phox) did not cross-react with 
membrane fractions isolated from human fibroblasts. In addi- 
tion, they showed that fibroblasts isolated from a patient suffer- 
ing from the X-linked form of chronic granulomatous disease 
(CGD), a genetic disorder which renders phagocytes unable to 
generate superoxide due to a defect within cytochrome b55s, 
were capable of generating an amount of superoxide equivalent 
to that produced by fibroblasts obtained from a healthy donor. 
These combined observations suggest hat human fibroblasts 
may express an isoenzyme of NADPH oxidase. The apparent 
presence of an alternative b-type cytochrome capable of fulfill- 
ing the role of gp91-phox may be supported by the recent 
identification of a novel 30 kDa cytochrome b which shares a 
sub-cellular location with cytochrome b55s in activated and rest- 
ing neutrophils [29]. 
Our RT-PCR data clearly demonstrate that human fibro- 
blasts express mRNA for p22-phox. Expression of p22-phox 
has previously been reported in other non-phagocytic cell types 
[30]. However, Meier et al. [20] reported a lack of immuno- 
detectable p22-phox inhuman fibroblasts. It has been suggested 
that the stability of cytochrome bss8 is dependent upon the 
presence of both subunits (p22-phox and gp9 l-phox) as muta- 
Table 2 
Cell-free recostruction of human neutrophil and human fibroblast cell 
fractions. Cell-free reconstruction was performed as described in the 
Materials and Methods and the data obtained from two independent 
assays are shown. Theproduction of superoxide is represented as nano- 
moles of superoxide/minute//tg of membrane protein 
nmoles up./mirg/tg 
mem. protein 
Exp. 1 Exp. 2 
(a) Homologous cell free reconstitution 
5/ag Neutrophil membranes + 100/~g 
Neutrophil cytosol 15.60 
5/ag Fibroblast membranes + 100/ag 
Fibroblast cytosol 0.16 
(b) Heterologous cell free reconstitution 
5/tg Neutrophil membranes + 100/tg 
Fibroblast cytosol 0.20 
5/ag Fibroblast membranes + 100/ag 
Neutrophil cytosol 0.10 
(c) Control assays 
5/ag Neutrophil membranes only 0.00 
5/lg Fibroblast membranes only 0.00 
100/ag Neutrophil membranes only 0.00 
100/ag Fibroblast cytosol only 0.00 
16.10 
0.18 
0.19 
0.13 
0.00 
0.00 
0.00 
0.00 
tions within either subunit, as observed in X-linked forms of 
CGD, result in either trace amounts or a complete absence of 
the other subunit [13]. A similar situation has been observed 
using the baculovirus expression of cytochrome b55s, where 
expression of a stable cytochrome b was dependent upon the 
co-transfection f p22-phox and gp91-phox cDNA [31]. 
RT-PCR showed that human fibroblasts, cultured in the 
presence of 10% FCS, express low levels of p47-phox and p67- 
phox mRNA. To confirm the presence of these cytosolic 
NADPH oxidase components we have used Western blot anal- 
ysis. This identified a specific 47 kDa protein band in TCA- 
precipitated fibroblast cytosol. Previous reports have shown 
the protein expression of p47-phox in the hepatoma cell line 
HepG2 [26] and human glomerular mesangial cells (Jones et al., 
in press). The data obtained from similar experiments using an 
anti-p67-phox antibody were less conclusive and only suggested 
the presence of p67-phox in human fibroblasts, as additional 
protein bands were also identified (data not shown). 
Cell-free reconstitution assays are widely used in the study 
of superoxide generation by phagocytes. Isolation of mem- 
branes and recombination with either cytosol or recombinant 
cytosolic proteins has allowed the identification of much of the 
protein components required for superoxide generation by 
these cells [32,11]. Using this assay sytem, it has previously been 
shown that the limited production of superoxide by EBV-trans- 
formed B-lymphocytes was due to a low amount of membrane- 
bound components a the levels ofcytosolic factors approached 
those found in neutrophils [33]. We have found that cell-free 
reconstitution of fibroblast cytosol and membranes promoted 
a low level production of superoxide (approximately 1% of that 
generated by the neutrophil membrane-cytosol c ntrol). To 
establish whether fibroblast cytosol could mediate superoxide 
production by neutrophil membranes, fibroblast cytosol was 
mixed with resting neutrophil membranes. The generation of
superoxide in this mixed cell reconstitution assay was also low, 
approximately 1-2% of the neutrophil control. This low level 
production of superoxide may be attributed to the relatively 
low abundance of fibroblast-derived cytosolic factors which 
may be rate-limiting for enzyme activity. Alternatively, the lim- 
ited production of superoxide observed within this mixed-cell 
assay may relate to an incompatibility of the fibroblast compo- 
nents with those possessed by the neutrophil. These data, how- 
ever, show that the enzymic activity of neutrophil membranes 
can be restored by fibroblast cytosol and therefore fibroblasts 
may contain factors related to the cytosolic omponents of the 
neutrophil NADPH oxidase. 
Previous tudies have demonstrated that the neutrophil p47- 
phox and p67-phox share a substantial degree of homology with 
the SH3 domains of non-receptor tyrosine kinases [9,10]. These 
domains may regulate the association of proteins to the cy- 
toskeleton [34]. It has been proposed that the docking of p47- 
phox and p67-phox involves an interaction of SH3 domains 
with a proline-rich region of p22-phox [35]. It is therefore con- 
ceivable that the 1M7-phox and p67-phox homologues identified 
in human fibroblasts associate with the cytoskeleton i  a similar 
fashion and this could support the presence of a p22-phox 
homologue in human fibroblasts. 
In conclusion, the superoxide-generating system of human 
fibroblasts appears to be related to the NADPH oxidase of 
phagocytic leukocytes. A variation within the gp91-phox cyto- 
chrome b component may suggest the presence of an NADPH 
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oxidase isoenzyme, which as yet remains only partially char- 
acterised. The importance of this putative isoform may be sig- 
nificant since the presence of radical-generating isoenzymes 
have been documented for nitric oxide synthase [36,37] and 
haem oxygenase [38,39]. In particular, the presence of constitu- 
tive and inducible forms of nitric oxide synthase appear to 
correlate with enzymatic function (see [40] for review). Further 
studies are therefore required to examine the regulation of the 
fibroblast NADPH oxidase system, particularly in response to 
pro-inflammatory c tokines (IL-lfl and TNFct), which have 
been shown to stimulate fibroblast production of superoxide 
[14,41]. Previous studies have reported that reactive oxygen 
species can induce fibroblast proliferation [42] and chemotaxis 
[43]. The production of reactive oxygen species may therefore 
be of importance in the inflammatory esponse, particularly in 
the development of fibrosis as observed in many chronic in- 
flammatory diseases, such as idiopathic pulmonary fibrosis. 
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